Júnior Ferreira
Daily Remedy unveiled two courses for physicians and health administrators to participate in.
The first course explains how to develop and submit amicus briefs for healthcare cases.
The second course details common investigational tactics used by federal authorities to target physicians.
You can register for either course at the link below:
https://www.daily-remedy.com/courses/
#thedailyremedy
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more
